What is ACUR stock price today?

ACUR (Acura Pharmaceuticals Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACUR stock going up or down today?

ACUR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACUR stock now?

The decision to buy ACUR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACUR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACUR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACUR stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACUR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACUR's P/E ratio?

P/E ratio data for ACUR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACUR's market cap?

ACUR (Acura Pharmaceuticals Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is ACUR's price to book ratio?

ACUR trades at a price-to-book (P/B) ratio of 24.11, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACUR pay dividends?

ACUR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACUR's dividend yield?

ACUR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACUR stock a good long-term investment?

ACUR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACUR's revenue growth rate?

ACUR has shown revenue growth of -0.9% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

ACUR is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in ACUR?

Key risks for ACUR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACUR compare to its competitors?

Compare ACUR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACUR's performance and positioning.

What is ACUR's stock price target for 2026?

Our AI model provides price targets for ACUR based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACUR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACUR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACUR's next earnings report?

ACUR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACUR - Acura Pharmaceuticals Inc

NYSE * Health Care * Biotechnology

$0.00

+$0.00 (+0.00%)

About Acura Pharmaceuticals Inc

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

ACUR Key Statistics

Market Cap

$0.03M

P/B Ratio

24.11

Revenue Growth

-0.9%

Profit Margin

-0.6%

Employees

How ACUR Compares to Peers

ACUR is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACUR(This stock)	$33.00K	N/A	-1%	-0.6%	-
AMGNAmgen Inc	$178.24B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.03B	19.2	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.35B	31.2	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.77B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Acura Pharmaceuticals Inc Company Information

Headquarters: Illinois; U.S.A
Website: www.acurapharm.com
Sector: Health Care
Industry: Biotechnology

About Acura Pharmaceuticals Inc

ACUR Key Statistics

How ACUR Compares to Peers

Acura Pharmaceuticals Inc Company Information

Upcoming Events for ACUR